Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes? Wendy H. UpdikeOlivia PaneNicholas W. Carris Current Opinion 30 April 2021 Pages: 881 - 893
IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses Youkyung S. RohJustin ChoiShawn G. Kwatra Leading Article 21 April 2021 Pages: 895 - 905
Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review Marta S. PalmeirimSabine SpechtJennifer Keiser Review Article Open access 30 April 2021 Pages: 907 - 921
Targeting AMPK by Statins: A Potential Therapeutic Approach Sajad DehnaviAmirhossein KianiAmirhossein Sahebkar Review Article Open access 03 May 2021 Pages: 923 - 933
Fostamatinib: A Review in Chronic Immune Thrombocytopenia Julia Paik Adis Drug Evaluation 10 May 2021 Pages: 935 - 943
Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia Connie KangYahiya Y. Syed Adis Drug Evaluation 10 May 2021 Pages: 945 - 952
Melphalan Flufenamide (Melflufen): First Approval Sohita Dhillon AdisInsight Report 07 May 2021 Pages: 963 - 969
